Clinical Trials Logo

Clinical Trial Summary

Bone conduction implants (BCI) are widely used in cases of conductive/ mixed hearing loss or single side deafness when surgical treatment or air hearing aids are not feasible. There are two types of BCI, abutments (which pass through the skin) and magnets (where a subcutaneous magnet is coupled to an external magnet). Pathologies (such as cholesteatoma) leading to the insertion of this hearing implant often require prolonged MRI follow-up. However, both the abutment and the magnet are responsible for imaging artifacts that limit its interpretation. Frequency and extent of these artifacts remain unclear in the literature. In our experience, the magnet, due to its size and composition, produces larger artifacts than the abutment. The main objective of our study is to compare MRI artifacts for each of these device types (abutment and magnet).


Clinical Trial Description

The patients included in the study will all have a cerebral MRI as part of the cholesteatoma follow-up or for the assessment of cerebral or inner ear pathology. - ENT evaluation: The position of the implant will be evaluated. The distance from the external ear canal (center of the abutment or center of the magnet) will be measured on the patient using a ribbon meter. The angle between the implant and the orbital plane (in degrees) will be evaluated on a profile photograph. - Imaging evaluation: MRI examinations will be anonymized and sent to a single core laboratory for reading. One reader, a board-certified neuroradiologist with 5 years of experience in inner ear imaging, blinded to all data, will review all MRI examinations on a dedicated workstation with the Carestream Vue PACS software (Carestream Health, Rochester, NY). The main outcome measures will be the size of artifacts and the interpretability of sequences. The following MRI sequences will be performed on a 1.5T scanner (1.5T Philips®, Ingenia), covering the temporal bones : ROUTINE SEQUENCES - 2D Diffusion weighted-imaging (WI) - High-resolution 3D T2-WI TSE (DRIVE) - Post-contrast 2D T1-WI TSE (axial and coronal planes) ADDITIONAL SEQUENCES (approximately 20 minutes of additional acquisition time) : - 2D DWI (axial and coronal) phase inverted - 2D T2-WI TSE (axial and coronal planes) - High-resolution 3D T2-WI gradient echo (bFFE) - post contrast 3D T1-WI TSE and gradient echo (THRIVE) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04448600
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status Completed
Phase
Start date September 28, 2020
Completion date September 26, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT02608944 - Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging N/A
Recruiting NCT04600115 - New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) Early Phase 1
Recruiting NCT03891511 - TMJ Fibrocartilage Detection Using MRI
Not yet recruiting NCT04871555 - Structural Cartography of the Insula in Temporal Epilepsy Patients
Completed NCT02318550 - Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD
Recruiting NCT04171635 - Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy